Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: A large cohort study from a single institute in China

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Yu, Xiao Juan ^a   Yu, Feng ^a   Song, Di ^a   Wang, Su Xia ^a   Song, Yan ^b   Liu, Gang ^a   Zhao, Ming Hui ^a,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CHINA; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULOPATHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; KIDNEY BIOPSY; KIDNEY THROMBOTIC MICROANGIOPATHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; PREDICTION; RENOVASCULAR DISEASE; BIOPSY; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; PLASMAPHERESIS; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PLASMA EXCHANGE; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907247095     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/680502     Document Type: Article

References (31)

1. Barbour T., Johnson S., Cohney S., Hughes P., Thrombotic microangiopathy and associated renal disorders. Nephrology Dialysis Transplantation 2012 27 7 2673 2685 10.1093/ndt/gfs279 2-s2.0-84864402709
2. Fernández J. L., Rojo J. C., Martín G. Í., Alonso R. M., Martín J. V., Hemolytic uremic syndrome: long term renal injury. Anales de Pediatria 2010 72 5 309 316 10.1016/j.anpedi.2009.12.016 2-s2.0-77952239110
3. Garg A. X., Suri R. S., Barrowman N., Rehman F., Matsell D., Rosas-Arellano M. P., Salvadori M., Haynes R. B., Clark W. F., Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. The Journal of the American Medical Association 2003 290 10 1360 1370 10.1001/jama.290.10.1360 2-s2.0-0041411081
4. Morel-Maroger L., Kanfer A., Solez K., Sraer J. D., Richet G., Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): clinicopathologic study in 20 adults. Kidney International 1979 15 5 548 558 10.1038/ki.1979.70 2-s2.0-0018647891
5. Benhamou Y., Assié C., Boelle P. Y., Buffet M., Grillberger R., Malot S., Wynckel A., Presne C., Choukroun G., Poullin P., Provôt F., Gruson D., Hamidou M., Bordessoule D., Pourrat J., Mira J., Le Guern V., Pouteil-Noble C., Daubin C., Vanhille P., Rondeau E., Palcoux J., Mousson C., Vigneau C., Bonmarchand G., Guidet B., Galicier L., Azoulay E., Rottensteiner H., Veyradier A., Coppo P., Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Haematologica 2012 97 8 1181 1186 10.3324/haematol.2011.049676 2-s2.0-84864764918
6. Caprioli J., Noris M., Brioschi S., Pianetti G., Castelletti F., Bettinaglio P., Mele C., Bresin E., Cassis L., Gamba S., Porrati F., Bucchioni S., Monteferrante G., Fang C. J., Liszewski M. K., Kavanagh D., Atkinson J. P., Remuzzi G., Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006 108 4 1267 1279 10.1182/blood-2005-10-007252 2-s2.0-33747159590
7. Noris M., Caprioli J., Bresin E., Mossali C., Pianetti G., Gamba S., Daina E., Fenili C., Castelletti F., Sorosina A., Piras R., Donadelli R., Maranta R., Van Der Meer I., Conway E. M., Zipfel P. F., Goodship T. H., Remuzzi G., Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clinical Journal of the American Society of Nephrology 2010 5 10 1844 1859 10.2215/CJN.02210310 2-s2.0-77958587405
8. Fremeaux-Bacchi V., Fakhouri F., Garnier A., Bienaimé F., Dragon-Durey M., Ngo S., Moulin B., Servais A., Provot F., Rostaing L., Burtey S., Niaudet P., Deschênes G., Lebranchu Y., Zuber J., Loirat C., Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide french series comparing children and adults. Clinical Journal of the American Society of Nephrology 2013 8 4 554 562 10.2215/CJN.04760512 2-s2.0-84876044818
9. Wu L. H., Yu F., Tan Y., Qu Z., Chen M., Wang S., Liu G., Zhao M., Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney International 2013 83 4 715 723 10.1038/ki.2012.409 2-s2.0-84875743388
10. Karpman D., Tati R., Complement activation in thrombotic microangiopathy. Hamostaseologie 2013 33 2 96 104 10.5482/HAMO-12-12-0025 2-s2.0-84881518113
11. Chang A., Thrombotic microangiopathy and the kidney: a nephrologist's perspective. Diagnostic Histopathology 2013 19 5 158 165
12. Wyllie B. F., Garg A. X., Macnab J., Rock G. A., Clark W. F., Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. British Journal of Haematology 2006 132 2 204 209 10.1111/j.1365-2141.2005.05857.x 2-s2.0-33644829278
13. Rose M., Rowe J. M., Eldor A., The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Reviews 1993 7 2 94 103 10.1016/S0268-960X(05)80019-0 2-s2.0-0027284394
14. Legendre C. M., Licht C., Muus P., Greenbaum L. A., Babu S., Bedrosian C., Bingham C., Cohen D. J., Delmas Y., Douglas K., Eitner F., Feldkamp T., Fouque D., Furman R. R., Gaber O., Herthelius M., Hourmant M., Karpman D., Lebranchu Y., Mariat C., Menne J., Moulin B., Nürnberger J., Ogawa M., Remuzzi G., Richard T., Sberro-Soussan R., Severino B., Sheerin N. S., Trivelli A., Zimmerhackl L. B., Goodship T., Loirat C., Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. The New England Journal of Medicine 2013 368 23 2169 2181 10.1056/NEJMoa1208981 2-s2.0-84878589219
15. Fakhouri F., Vercel C., Frémeaux-Bacchi V., Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clinical Journal of the American Society of Nephrology 2012 7 12 2100 2106 10.2215/CJN.13121211 2-s2.0-84876823275
16. Yu F., Tan Y., Zhao M., Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome. Nephrology Dialysis Transplantation 2010 25 1 145 152 10.1093/ndt/gfp421 2-s2.0-72949104340
17. Wang F. M., Yu F., Tan Y., Song D., Zhao M., Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis. Rheumatology 2012 51 12 2269 2277 kes218 10.1093/rheumatology/kes218 2-s2.0-84870352731
18. Dragon-Durey M., Loirat C., Cloarec S., Macher M., Blouin J., Nivet H., Weiss L., Fridman W. H., Frémeaux-Bacchi V., Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2005 16 2 555 563 10.1681/ASN.2004050380 2-s2.0-20544437666
19. Cohen D., Koopmans M., Kremer H. I. C., Berger S. P., Van Groningen M. R., Steup-Beekman G. M., De Heer E., Bruijn J. A., Bajema I. M., Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis and Rheumatism 2008 58 8 2460 2469 10.1002/art.23662 2-s2.0-49449092487
20. George J. N., How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010 116 20 4060 4069 10.1182/blood-2010-07-271445 2-s2.0-78549253211
21. Fujimura Y., Matsumoto M., Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Internal Medicine 2010 49 1 7 15 10.2169/internalmedicine.49.2706 2-s2.0-74549138555
22. Fan X., Yoshida Y., Honda S., Matsumoto M., Sawada Y., Hattori M., Hisanaga S., Hiwa R., Nakamura F., Tomomori M., Miyagawa S., Fujimaru R., Yamada H., Sawai T., Ikeda Y., Iwata N., Uemura O., Matsukuma E., Aizawa Y., Harada H., Wada H., Ishikawa E., Ashida A., Nangaku M., Miyata T., Fujimura Y., Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Molecular Immunology 2013 54 2 238 246 10.1016/j.molimm.2012.12.006 2-s2.0-84872174501
23. Tsai H. M., Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. The American Journal of Medicine 2013 126 3 200 209 10.1016/j.amjmed.2012.09.006 2-s2.0-84873650966
24. George J. N., Vesely S. K., Terrell D. R., Deford C. C., Reese J. A., Al-Nouri Z. L., Stewart L. M., Lu K. H., Muthurajah D. S., The oklahoma thrombotic thrombo-cytopenic purpura-haemolytic uraemic syndrome registry a model for clinical research, education and patient care. Hamostaseologie 2013 33 2 105 112 10.5482/HAMO-12-10-0016 2-s2.0-84881532348
25. Levandovsky M., Harvey D., Lara P., Wun T., Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients. Journal of Hematology and Oncology 2008 1 1, article 23 10.1186/1756-8722-1-23 2-s2.0-70450123543
26. Scully M., Hunt B. J., Benjamin S., Liesner R., Rose P., Peyvandi F., Cheung B., Machin S. J., Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. The British Journal of Haematology 2012 158 3 323 335 10.1111/j.1365-2141.2012.09167.x 2-s2.0-84863841323
27. Taylor C. M., MacHin S., Wigmore S. J., Goodship T. H. J., Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom. The British Journal of Haematology 2010 148 1 37 47 10.1111/j.1365-2141.2009.07916.x 2-s2.0-72249097911
28. Abildgaard U., Heimdal K., Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. European Journal of Obstetrics Gynecology and Reproductive Biology 2013 166 2 117 123 10.1016/j.ejogrb.2012.09.026 2-s2.0-84873161255
29. Maynard S. E., Min J. Y., Merchan J., Lim K., Li J., Mondal S., Libermann T. A., Morgan J. P., Sellke F. W., Stillman I. E., Epstein F. H., Sukhatme V. P., Karumanchi S. A., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 2003 111 5 649 658 10.1172/JCI200317189 2-s2.0-0037373006
30. Pourrat O., Coudroy R., Pierre F., ADAMTS13 deficiency in severe postpartum HELLP syndrome. British Journal of Haematology 2013 10.1111/bjh.12494 2-s2.0-84880350078
31. Ardissino G., Ossola M. W., Baffero G. M., Rigotti A., Cugno M., Eculizumab for atypical hemolytic uremic syndrome in pregnancy. Obstetrics and Gynecology 2013 122 2, part 2 487 489 10.1097/AOG.0b013e31828e2612 2-s2.0-84880958391